4//SEC Filing
Komjathy Andrew 4
Accession 0001104659-23-068345
CIK 0001454789other
Filed
Jun 5, 8:00 PM ET
Accepted
Jun 6, 8:07 AM ET
Size
19.8 KB
Accession
0001104659-23-068345
Insider Transaction Report
Form 4
Komjathy Andrew
Chief Commercial Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-06-02+80,000→ 80,000 totalExercise: $13.36Exp: 2033-01-31→ Common Stock (80,000 underlying)
Footnotes (2)
- [F1]This option was by granted effective as of February 1, 2023, subject to stockholder approval of an amendment to Astria Therapeutics, Inc.'s (the "Company") Amended and Restated 2015 Stock Incentive Plan to increase the number of shares available for issuance thereunder by 4,300,000 (the "Stock Plan Amendment Proposal"). The Company's stockholders approved the Stock Plan Amendment Proposal on June 2, 2023.
- [F2]This option was granted on February 1, 2023 and is subject to vesting over a four-year period, with 25% of the 80,000 shares underlying the option upon grant vesting on the first anniversary of February 1, 2023 and the remainder vesting over the ensuing three years in equal monthly installments.
Issuer
Astria Therapeutics, Inc.
CIK 0001454789
Entity typeother
Related Parties
1- filerCIK 0001788465
Filing Metadata
- Form type
- 4
- Filed
- Jun 5, 8:00 PM ET
- Accepted
- Jun 6, 8:07 AM ET
- Size
- 19.8 KB